Esperite

Esperite Current Liabilities

Delisted

The Current Liabilities of Esperite (ESP.AS) as of Nov 17, 2026 is 14.55 M EUR. In the previous year, Current Liabilities was 16.44 M EUR — a change of -11.47% (lower).

Current Liabilities

14.55 MEUR

YoY

-11.47%

Last updated:

Current Liabilities of Esperite is 2017 14.55 M EUR. Current Liabilities of Esperite was 2016 16.44 M EUR. It decreases by -11.47% lower compared to the previous year.

The Esperite Current Liabilities history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Current Liabilities
Date
Current Liabilities
Jan 1, 2010
8.98 M EUR
Jan 1, 2011
8.94 M EUR
Jan 1, 2012
9.31 M EUR
Jan 1, 2013
9.20 M EUR
Jan 1, 2014
8.76 M EUR
Jan 1, 2015
13.80 M EUR
Jan 1, 2016
16.44 M EUR
Jan 1, 2017
14.55 M EUR
The Esperite Current Liabilities history
YEARCurrent LiabilitiesYoY
14.55 MEUR-11.47%
16.44 MEUR+19.10%
13.80 MEUR+57.60%
8.76 MEUR-4.82%
9.20 MEUR-1.15%
9.31 MEUR+4.14%
8.94 MEUR-0.45%
8.98 MEUR-12.98%
10.32 MEUR+38.71%
7.44 MEUR+39.85%
5.32 MEUR+107.00%
2.57 MEUR+55.76%
1.65 MEUR+28.91%
1.28 MEUR—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Esperite Stock analysis

What does Esperite do? Esperite NV is a company based in the Netherlands that specializes in the development, production, and marketing of stem cell and cell therapies. It focuses on creating groundbreaking therapies for the treatment of serious diseases and aims to market them worldwide. Its business model includes three main segments: Life Science, Consumer Healthcare, and Branding. The Life Science segment focuses on developing stem cell and cell therapies for the treatment of diseases such as autism, cancer, and degenerative disorders. The Consumer Healthcare segment offers products related to pregnancy and fertility assistance. The Branding segment involves the development and marketing of high-quality cosmetic products. Esperite's flagship product is CryoSave, a solution for the long-term preservation of stem cells from umbilical cord blood. Esperite is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Esperite stock

Current Liabilities of Esperite is 14.55 M EUR in 2017.

Current Liabilities of Esperite changed from 16.44 M EUR to 14.55 M EUR, representing a -11.47% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Current Liabilities Esperite since 2006 – with annual values, charts, and detailed analysis.

Current liabilities are obligations due within one year, including accounts payable, short-term debt, and accrued expenses.

Current Liabilities's EUR is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Current Liabilities's Esperite historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Balance Sheet — Esperite

All Key Metrics — Esperite